CGEN
Price
$2.58
Change
+$0.04 (+1.57%)
Updated
Mar 28, 6:59 PM EST
41 days until earnings call
VBIV
Price
$0.60
Change
+$0.02 (+3.45%)
Updated
Mar 28, 6:59 PM EST
Ad is loading...

Analysis and predictions CGEN vs VBIV

Header iconCGEN vs VBIV Comparison
Open Charts CGEN vs VBIVBanner chart's image
Compugen
Price$2.58
Change+$0.04 (+1.57%)
Volume$182.72K
CapitalizationN/A
VBI Vaccines
Price$0.60
Change+$0.02 (+3.45%)
Volume$89.08K
CapitalizationN/A
View a ticker or compare two or three
CGEN vs VBIV Comparison Chart

Loading...

CGENDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VBIVDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CGEN vs. VBIV commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGEN is a Hold and VBIV is a Hold.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (CGEN: $2.57 vs. VBIV: $0.61)
Brand notoriety: CGEN and VBIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGEN: 41% vs. VBIV: 85%
Market capitalization -- CGEN: $228.96M vs. VBIV: $14.41M
CGEN [@Biotechnology] is valued at $228.96M. VBIV’s [@Biotechnology] market capitalization is $14.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $570.99B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGEN’s FA Score shows that 0 FA rating(s) are green whileVBIV’s FA Score has 1 green FA rating(s).

  • CGEN’s FA Score: 0 green, 5 red.
  • VBIV’s FA Score: 1 green, 4 red.
According to our system of comparison, CGEN is a better buy in the long-term than VBIV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGEN’s TA Score shows that 3 TA indicator(s) are bullish while VBIV’s TA Score has 4 bullish TA indicator(s).

  • CGEN’s TA Score: 3 bullish, 5 bearish.
  • VBIV’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VBIV is a better buy in the short-term than CGEN.

Price Growth

CGEN (@Biotechnology) experienced а -3.75% price change this week, while VBIV (@Biotechnology) price change was +7.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.98%. For the same industry, the average monthly price growth was +8.91%, and the average quarterly price growth was +90.55%.

Reported Earning Dates

CGEN is expected to report earnings on May 09, 2024.

VBIV is expected to report earnings on Aug 09, 2023.

Industries' Descriptions

@Biotechnology (+4.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CGEN with price predictions.
OPEN
A.I.dvisor published
a Summary for VBIV with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CGEN($229M) has a higher market cap than VBIV($14.4M). CGEN YTD gains are higher at: 29.798 vs. VBIV (3.557). CGEN has higher annual earnings (EBITDA): -12.52M vs. VBIV (-104.08M). CGEN has more cash in the bank: 50.7M vs. VBIV (35.5M). CGEN has less debt than VBIV: CGEN (1.35M) vs VBIV (52.7M). CGEN has higher revenues than VBIV: CGEN (33.5M) vs VBIV (8.12M).
CGENVBIVCGEN / VBIV
Capitalization229M14.4M1,590%
EBITDA-12.52M-104.08M12%
Gain YTD29.7983.557838%
P/E RatioN/AN/A-
Revenue33.5M8.12M412%
Total Cash50.7M35.5M143%
Total Debt1.35M52.7M3%
FUNDAMENTALS RATINGS
CGEN vs VBIV: Fundamental Ratings
CGEN
VBIV
OUTLOOK RATING
1..100
7376
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
16
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9699
PRICE GROWTH RATING
1..100
3563
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VBIV's Valuation (16) in the Biotechnology industry is in the same range as CGEN (42). This means that VBIV’s stock grew similarly to CGEN’s over the last 12 months.

VBIV's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CGEN (100). This means that VBIV’s stock grew similarly to CGEN’s over the last 12 months.

CGEN's SMR Rating (96) in the Biotechnology industry is in the same range as VBIV (99). This means that CGEN’s stock grew similarly to VBIV’s over the last 12 months.

CGEN's Price Growth Rating (35) in the Biotechnology industry is in the same range as VBIV (63). This means that CGEN’s stock grew similarly to VBIV’s over the last 12 months.

CGEN's P/E Growth Rating (100) in the Biotechnology industry is in the same range as VBIV (100). This means that CGEN’s stock grew similarly to VBIV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CGENVBIV
RSI
ODDS (%)
Bearish Trend 1 day ago
86%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
87%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 18 days ago
87%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 15 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
N/A
View a ticker or compare two or three
Ad is loading...
CGENDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VBIVDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CSTM22.110.38
+1.75%
Constellium SE
TOMZ0.680.01
+1.43%
TOMI Environmental Solutions
MOND2.280.02
+0.88%
Mondee Holdings
VVI39.490.01
+0.03%
Viad Corp
ASX10.99-0.01
-0.09%
ASE Technology Holding Co Ltd

CGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEN has been loosely correlated with NGNE. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEN jumps, then NGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEN
1D Price
Change %
CGEN100%
+1.18%
NGNE - CGEN
51%
Loosely correlated
+3.13%
ORMP - CGEN
40%
Loosely correlated
+3.55%
CRSP - CGEN
40%
Loosely correlated
-2.85%
AVRO - CGEN
39%
Loosely correlated
+2.38%
CYTK - CGEN
38%
Loosely correlated
-1.82%
More

VBIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, VBIV has been loosely correlated with MDGL. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if VBIV jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VBIV
1D Price
Change %
VBIV100%
+4.90%
MDGL - VBIV
56%
Loosely correlated
+3.18%
AXON - VBIV
48%
Loosely correlated
-0.98%
CYTK - VBIV
44%
Loosely correlated
-1.82%
ORMP - VBIV
42%
Loosely correlated
+3.55%
ONCT - VBIV
40%
Loosely correlated
+12.11%
More